Cancertope

In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results


The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE


NeoepitopesVRRYTSTVL        Click here to BLAST against human proteome
CTL Epitope
(CTLPred)
N
HLA I Alleles
(ProPred I)
HLA-B14, HLA-B*2702, HLA-B*2705, HLA-B*51, HLA-B75
HLA I Alleles
(nHLAPred)
NA0
HLA II Alleles
(PrePred)
DRB1_0101, DRB1_0102, DRB1_0402, DRB1_0404, DRB1_0405, DRB1_0408, DRB1_0410, DRB1_0423, DRB1_0701, DRB1_0703, DRB1_0804, DRB1_0806, DRB1_0813, DRB1_1501, DRB1_1502, DRB1_1506, DRB5_0101, DRB5_010518
B_Cell_Epitope
(ABCPred)
N

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package